95 related articles for article (PubMed ID: 9397428)
1. Decreasing striatal 6-FDOPA uptake with increasing duration of cocaine withdrawal.
Wu JC; Bell K; Najafi A; Widmark C; Keator D; Tang C; Klein E; Bunney BG; Fallon J; Bunney WE
Neuropsychopharmacology; 1997 Dec; 17(6):402-9. PubMed ID: 9397428
[TBL] [Abstract][Full Text] [Related]
2. Cocaine withdrawal and the cerebral influx of [18F]fluoro-L-DOPA (FDOPA).
Cumming P; Reith J; Gjedde A
Neuropsychopharmacology; 1999 Apr; 20(4):395-8. PubMed ID: 10088142
[No Abstract] [Full Text] [Related]
3. Striatal 6-[18F]fluorodopa accumulation after combined inhibition of peripheral catechol-O-methyltransferase and monoamine oxidase type B: differing response in relation to presynaptic dopaminergic dysfunction.
Ruottinen HM; Rinne JO; Oikonen VJ; Bergman JR; Haaparanta MT; Solin OH; Ruotsalainen UH; Rinne UK
Synapse; 1997 Dec; 27(4):336-46. PubMed ID: 9372556
[TBL] [Abstract][Full Text] [Related]
4. Striatal 18F-dopa uptake: absence of an aging effect.
Eidelberg D; Takikawa S; Dhawan V; Chaly T; Robeson W; Dahl R; Margouleff D; Moeller JR; Patlak CS; Fahn S
J Cereb Blood Flow Metab; 1993 Sep; 13(5):881-8. PubMed ID: 8360294
[TBL] [Abstract][Full Text] [Related]
5. Fluorodopa positron emission tomography with an inhibitor of catechol-O-methyltransferase: effect of the plasma 3-O-methyldopa fraction on data analysis.
Ishikawa T; Dhawan V; Chaly T; Robeson W; Belakhlef A; Mandel F; Dahl R; Margouleff C; Eidelberg D
J Cereb Blood Flow Metab; 1996 Sep; 16(5):854-63. PubMed ID: 8784230
[TBL] [Abstract][Full Text] [Related]
6. The effects of carbidopa administration on 6-[18F]fluoro-L-dopa kinetics in positron emission tomography.
Hoffman JM; Melega WP; Hawk TC; Grafton SC; Luxen A; Mahoney DK; Barrio JR; Huang SC; Mazziotta JC; Phelps ME
J Nucl Med; 1992 Aug; 33(8):1472-7. PubMed ID: 1634937
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of striatal DOPA decarboxylase activity in Parkinson's disease.
Ishikawa T; Dhawan V; Chaly T; Margouleff C; Robeson W; Dahl JR; Mandel F; Spetsieris P; Eidelberg D
J Nucl Med; 1996 Feb; 37(2):216-22. PubMed ID: 8667047
[TBL] [Abstract][Full Text] [Related]
8. (18)F-FDOPA PET for differentiating recurrent or progressive brain metastatic tumors from late or delayed radiation injury after radiation treatment.
Lizarraga KJ; Allen-Auerbach M; Czernin J; DeSalles AA; Yong WH; Phelps ME; Chen W
J Nucl Med; 2014 Jan; 55(1):30-6. PubMed ID: 24167081
[TBL] [Abstract][Full Text] [Related]
9. Extrastriatal mean regional uptake of fluorine-18-FDOPA in the normal aged brain--an approach using MRI-aided spatial normalization.
Nagano AS; Ito K; Kato T; Arahata Y; Kachi T; Hatano K; Kawasumi Y; Nakamura A; Yamada T; Abe Y; Ishigaki T
Neuroimage; 2000 Jun; 11(6 Pt 1):760-6. PubMed ID: 10860800
[TBL] [Abstract][Full Text] [Related]
10. Plasma homovanillic acid and the dopamine transporter during cocaine withdrawal.
Bowers MB; Malison RT; Seibyl JP; Kosten TR
Biol Psychiatry; 1998 Feb; 43(4):278-81. PubMed ID: 9513737
[TBL] [Abstract][Full Text] [Related]
11. Input functions for 6-[fluorine-18]fluorodopa quantitation in parkinsonism: comparative studies and clinical correlations.
Takikawa S; Dhawan V; Chaly T; Robeson W; Dahl R; Zanzi I; Mandel F; Spetsieris P; Eidelberg D
J Nucl Med; 1994 Jun; 35(6):955-63. PubMed ID: 8195882
[TBL] [Abstract][Full Text] [Related]
12. Kinetics and modeling of L-6-[18F]fluoro-dopa in human positron emission tomographic studies.
Huang SC; Yu DC; Barrio JR; Grafton S; Melega WP; Hoffman JM; Satyamurthy N; Mazziotta JC; Phelps ME
J Cereb Blood Flow Metab; 1991 Nov; 11(6):898-913. PubMed ID: 1939385
[TBL] [Abstract][Full Text] [Related]
13. Automated striatal uptake analysis of ¹⁸F-FDOPA PET images applied to Parkinson's disease patients.
Chang IC; Lue KH; Hsieh HJ; Liu SH; Kao CH
Ann Nucl Med; 2011 Dec; 25(10):796-803. PubMed ID: 21887536
[TBL] [Abstract][Full Text] [Related]
14. PET studies of net blood-brain clearance of FDOPA to human brain: age-dependent decline of [18F]fluorodopamine storage capacity.
Kumakura Y; Vernaleken I; Gründer G; Bartenstein P; Gjedde A; Cumming P
J Cereb Blood Flow Metab; 2005 Jul; 25(7):807-19. PubMed ID: 15729292
[TBL] [Abstract][Full Text] [Related]
15. Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients.
Hietala J; Syvälahti E; Vuorio K; Räkköläinen V; Bergman J; Haaparanta M; Solin O; Kuoppamäki M; Kirvelä O; Ruotsalainen U
Lancet; 1995 Oct; 346(8983):1130-1. PubMed ID: 7475604
[TBL] [Abstract][Full Text] [Related]
16. Effects of Smoking Cessation on Presynaptic Dopamine Function of Addicted Male Smokers.
Rademacher L; Prinz S; Winz O; Henkel K; Dietrich CA; Schmaljohann J; Mohammadkhani Shali S; Schabram I; Stoppe C; Cumming P; Hilgers RD; Kumakura Y; Coburn M; Mottaghy FM; Gründer G; Vernaleken I
Biol Psychiatry; 2016 Aug; 80(3):198-206. PubMed ID: 26803340
[TBL] [Abstract][Full Text] [Related]
17. PET imaging of dopamine transporter and drug craving during methadone maintenance treatment and after prolonged abstinence in heroin users.
Shi J; Zhao LY; Copersino ML; Fang YX; Chen Y; Tian J; Deng Y; Shuai Y; Jin J; Lu L
Eur J Pharmacol; 2008 Jan; 579(1-3):160-6. PubMed ID: 17977528
[TBL] [Abstract][Full Text] [Related]
18. Human striatal L-dopa decarboxylase activity estimated in vivo using 6-[18F]fluoro-dopa and positron emission tomography: error analysis and application to normal subjects.
Kuwabara H; Cumming P; Reith J; Léger G; Diksic M; Evans AC; Gjedde A
J Cereb Blood Flow Metab; 1993 Jan; 13(1):43-56. PubMed ID: 8417009
[TBL] [Abstract][Full Text] [Related]
19. Loss of metabolites from monkey striatum during PET with FDOPA.
Cumming P; Munk OL; Doudet D
Synapse; 2001 Sep; 41(3):212-8. PubMed ID: 11391782
[TBL] [Abstract][Full Text] [Related]
20. Plasma L-[18F]6-fluorodopa input function: a simplified method.
Chan GL; Morrison KS; Holden JE; Ruth TJ
J Cereb Blood Flow Metab; 1992 Sep; 12(5):881-4. PubMed ID: 1506454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
